Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...

Bibliografske podrobnosti
Main Authors:	Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Format:	Journal article
Jezik:	English
Izdano:	2012

Podobne knjige/članki

ERYTHROPOIETIN - A CANDIDATE TREATMENT FOR MOOD SYMPTOMS AND COGNITIVE DYSFUNCTION IN DEPRESSION
od: Miskowiak, K, et al.
Izdano: (2011)

Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
od: Miskowiak, K, et al.
Izdano: (2016)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
od: Miskowiak, K, et al.
Izdano: (2010)

Neural correlates of improved executive function following erythropoietin treatment in mood disorders
od: Miskowiak, K, et al.
Izdano: (2016)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
od: Paulson Olaf B, et al.
Izdano: (2010-10-01)

Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder
od: Miskowiak, K, et al.
Izdano: (2018)

Erythropoietin as candidate for supportive treatment of severe COVID-19
od: Hannelore Ehrenreich, et al.
Izdano: (2020-06-01)

Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach
od: Søren F. V. Nielsen, et al.
Izdano: (2019-11-01)

Erythropoietin enhances hippocampal response during memory retrieval in humans.
od: Miskowiak, K, et al.
Izdano: (2007)

Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial
od: Jeff Zarp Petersen, et al.
Izdano: (2018-11-01)

Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.
od: Miskowiak, K, et al.
Izdano: (2008)

Is negative self-referent bias an endophenotype for depression? An fMRI study of emotional self-referent words in twins at high vs. low risk of depression
od: Miskowiak, K, et al.
Izdano: (2017)

The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
od: Maj Vinberg, et al.
Izdano: (2015-01-01)

Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review
od: Ida Seeberg, et al.
Izdano: (2018-07-01)

Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients
od: Miskowiak, K, et al.
Izdano: (2009)

Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients
od: Miskowiak, K, et al.
Izdano: (2009)

Differences in neural and cognitive response to emotional faces in middle-aged dizygotic twins at familial risk of depression
od: Miskowiak, K, et al.
Izdano: (2017)

Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial
od: Lejla Sjanic Schmidt, et al.
Izdano: (2018-04-01)

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
od: Miskowiak, K, et al.
Izdano: (2009)

Is aberrant affective cognition an endophenotype for affective disorders? A monozygotic twin study
od: Meluken, I, et al.
Izdano: (2018)

Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.
od: Miskowiak, K, et al.
Izdano: (2007)

Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial.
od: Kirsa M Demant, et al.
Izdano: (2015-01-01)

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.
od: Miskowiak, K, et al.
Izdano: (2010)

Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives
od: Kjaerstad, H, et al.
Izdano: (2019)

Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?—A Perspective Paper
od: Lars Vedel Kessing, et al.
Izdano: (2018-10-01)

Predictors of mood and activity instability in participants with newly diagnosed bipolar disorder – Exploratory findings from a prospective cohort study
od: Anton Julius von Hofacker, et al.
Izdano: (2024-01-01)

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.
od: Miskowiak, K, et al.
Izdano: (2008)

Executive dysfunction and autobiographical memory retrieval in recovered depressed women.
od: Haddad, A, et al.
Izdano: (2014)

Erythropoietin enhances hippocampal long-term potentiation and memory
od: El-Kordi Ahmed, et al.
Izdano: (2008-09-01)

Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)—recommendations
od: Faurholt-Jepsen, M, et al.
Izdano: (2019)

Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)—recommendations
od: Faurholt-Jepsen, M, et al.
Izdano: (2019)

Erythropoietin – a potential tool in the treatment of depressive disorders?
od: G. Simões, et al.
Izdano: (2022-06-01)

Erythropoietin improves operant conditioning and stability of cognitive performance in mice
od: Ehrenreich Hannelore, et al.
Izdano: (2009-07-01)

Lack of effect of tyrosine depletion on mood in recovered depressed women.
od: McTavish, S, et al.
Izdano: (2005)

Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
od: Martin Begemann, et al.
Izdano: (2021-09-01)

Latent Classes of Symptoms related to Clinically Depressed Mood in Adolescents
od: Eva Henje Blom, et al.
Izdano: (2014-05-01)

Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial.
od: Adams, S, et al.
Izdano: (2013)

Affective disorders: eliminate WArning signs and REstore functioning—AWARE—a randomised controlled multimodule intervention study, presentation of design and intervention
od: Maj Vinberg, et al.
Izdano: (2022-05-01)

Bipolar mood disorder and treatment-resistant depression
od: Rybakowski Janusz K
Izdano: (2010-04-01)

Associations between the cortisol awakening response and patient-evaluated stress and mood instability in patients with bipolar disorder: an exploratory study
od: Maria Faurholt-Jepsen, et al.
Izdano: (2021-03-01)